DAFTAR PUSTAKA

1. Dorland WA, Newman. 2010. Dorland’s illustrated medical dictionary. Edisi

31. Jakarta : EGC.
2. Baldwij T. 2010. Obesity and public health. Toronto (CA): World Health
Organization.
3. WHO (2018). Obesity and overweight. World Health Organization.
https://www.who.int/news-room... ./obesity-and-overweight - Diakses Juni
2019.
4. WHO (2018). Prevalensi of overweight, crude. http://apps.who.int/gho
/...BMI25CREGv?lang=en – Diakses November 2019
5. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. 2015.
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic
assessment of prevalence, incidence, and outcomes. AASLD, 64(1);73-84.
6. Harbuwono DS, Pramono LA, Yunir E, Subekti I. 2018. Obesity and central
obesity in Indonesia: evidence from a national health survey. MJI, 27(2):114-
120.
7. Kurniawan R, Yudianto, Hardhana B, Siswanti T, editors. 2018. Indonesia
Health Profile tahun 2017. Jakarta: Ministry of Health RI.
8. Menteri Kesehatan Republik Indonesia (IDN). 2014. Peraturan Menteri
Kesehatan Republik Indonesia Nomor 41 Tahun 2014. Jakarta: Kementrian
Indonesia.
9. Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, et al.
2018. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty
Liver Disease. Pubmed, 2018;1-14.
10. Donne LD, Rossi R, Colombo R, Giustarini D, Milzani A. 2006. Biomarker
of Oxidative Damage in Human Disease. Clinical Chemistry, 52(4): 601-623.
11. Ayala A, Munoz M, Arguelles S. 2014. Lipid peroxidation: Production,
metabolism, and signaling mechanism of malondialdehyde and 4-hydroxy-2-
nonenal. Oxidative medicine and cellular longevity, 2014; 1-31.
12. Hasan I, Gani R, Machmud R. 2002. Prevalence and risk factors for
nonalcoholic fatty liver in Indonesia. J Gastroenterol Hepatol, 17: A30.

Fakultas Kedokteran Universitas Andalas 47

13. Noeman SA, Hamooda HE, Baalash AA. 2011. Biochemical study of
oxidative stress markers in the liver, kidney and heart of high fat diet induced
obesity in rats. Diabetology & metabolic syndrome, 3: 17.
14. Koda-Kimble, M. A., L. Y. Young, B. K. Alldredge, R. L. Corelli, B. J.
Guglielmo, W. A. Kradjan, dan B. R. Williams. 2009. Applied Therapeutics:
The Clinical Use Of Drugs. Edisi 9. Philapelphia: Lippincott Williams &
Wilkins.
15. Maria, L & Priscilla M.C. 2003. Oxidative stress, exercise, and antioxidant
supplementation. Journal Toxicology, 189: 41 – 45.
16. Llurba E, Grataco E, Galla MP, Cabero L, Dominguez C (2004). A
comprehensive study of oxidative stress and antioxidant status in
preeclampsia and normal pregnancy. Free Radical Biology & Medicine, 9:
515 – 540.
17. Adyttia A, Untari EK dan Wahdaningsih S (2014). Efek ekstrak etanol daun
premna cordifolia terhadap malondialdehida tikus yang dipapar asap rokok.
Pharmacology Scientific Research, 1(2): 104 – 115.
18. Yadav A, Kumari R, Yadav A, Mishra JP, Srivastava S, Prabha S. 2016.
Antioxidants and its function in human body: A review. Research in
Encironment and Life Science, 9; 1328-1331.
19. Muchtar H, Yeni G, Hermianti W, Diza YH. 2010. Pembuatan Konsentrat
Polifenol Gambir (Uncaria gambir Roxb) sebagai bahan antioksidan pangan.
J Ris Ind, 4: 71 – 82.
20. Isnawati A, Raini M, Sampurno OD, Mutiatikum D, Widowati L, Gitawati R.
2012. Karakterisasi tiga jenis ekstrak gambir (Uncaria gambir roxb) dari
Sumatera Barat. Bul Penelit Kesehat, 40(4): 201-8.
21. Musdja Y, Rahman HA, Hasan D. 2018. Antioxidant activity of catechins
isolate of uncaria gambier roxb in male rats. LIFE: International Journal of
Health and Life-Sciences, 4: 34-46.
22. Zanwar AA, Badole SL, Shende PS, Hegde MV, Bodhankar SL. 2014.
Polyphenols in Human Health and Disease. Science Direct, 1: 267-71.
23. Anbudhasan P, Surendraraj A, Karkuzhali S, Sathishkumaran S. 2014.
Natural antioxidants and its benefits. IJFANS, 3(6): 225-32.

Fakultas Kedokteran Universitas Andalas 48

24. Alioes Y, Sukma R, Sekar S. 2019. Effect of Gambir Catechin Isolate
(Uncaria Gambir Roxb.) Against Rat Triacylglycerol Level (Rattus
novergicus). IOP Conference Series: Earth and Environmental Science,
217(1): 1-6.
25. Ansori FA. 2018. Pengaruh pemberian kawa daun gambir (Uncaria gambir
Roxb) terhadap kadar malondialdehid (MDA) jaringan hati mencit (mus
muculus) diabetes yang diinduksi aloksan [skripsi]. Padang: Fakultas
Kedokteran Universitas Andalas.
26. Ali A, Amalia L, Suptijah P. 2015. Pemberian kitosan dan pengaruhnya
terhadap berat badan dan kadar trigliserida darah tikus sprague-dawley yang
diberi pakan asam lemak trans. Gizi Pangan, 10(1); 9-16.
27. Manurung LR, Mandera LI, editors. 2014. Harper’s illustrated biochemistry.
Jakarta: EGC.
28. Setiati S, Alwi I, Sudoyo AW, Simadibrata MK, Setiyohadi B, Syam AF,
editors. 2015. Buku ajar ilmu penyakit dalam edisi keenam jilid II. Jakarta:
Interna Publishing.
29. Botham KM, Mayes PA. 2009. Lipid yang Penting Secara Fisiologis.
In:Wulandari N, Rendy L, Dwijayanti L, Liena, Dany F, Rachman LY,
editors. Biokimia Harper. Edisi 27. Jakarta: EGC. hlm 128-37.
30. Apsubiology.org (2019). CH18 lipoproteins.
www.apsubiology.org/anatomy/2020/...Exam_1/CH18_Lipoproteins.htm -
Diakses Oktober 2019.
31. Kwan BCH, Kronenberg F, Beddhu S, Cheung AK (2007). Lipoprotein
metabolism and lipid management in chronic kidney disease. Journal of the
American Society of Nephrology. https://jasn.asnjournals.org/content
/18/.../tab-figures-data - Diakses Oktober 2019.
32. Boden G. 2008. Obesity anf free fatty acids (FFA). Philadelphia (PA): NIH
Public Access.
33. Kaustubh B. 2016. Obesity : Causes and cosequences. BioNE, 1(16): 1-6
34. Joon-Myung C, Chun-Bae K. 2011. Obesity management and scientific
evidence. Journal of the Korean Medical Association, 54: 250-65.

Fakultas Kedokteran Universitas Andalas 49

35. Redinger RN. 2007. The patophysiology of obesity and its clinical
manifestations. Gastroenterology & Hepatology, 3(11): 856-63.
36. Segula D. 2014. Complication of obesity in adults: A short review of the
literature. Malawi Medical Journal, 26(1): 20-4.
37. El-Kader SMA, Ashmawy EMSE. 2015. Non-alcoholic fatty liver disease :
The diagnosis and management. World J Hepatol, 7(6): 846-58.
38. Kleiner DE, Natta MV, Behling C, Contos M, Cummings O, Ferrell LD, et al.
2005. Design and validation of a histological scoring system for nonalcoholic
fatty liver disease. Hepatology, 41(6): 1313-21.
39. Dieahl AM, Day C. 2017. Cause, pathogenesis, and treatment of
nonalcoholic steatohepatitis. N Engl J Med, 377: 2063-72.
40. Cobbina E, Akhlaghi F. 2017. Non-Alcoholic Fatty Liver Disease (NAFLD) –
pathogenesis, classification, and effect on drug metabolizing enzymes and
transporters. Drug Metab Rev, 49(2): 197-211.
41. Albhaisi S, Sanyai A (2018). Recent advances in understanding and
managing non-alcoholic fatty liver disease. F1000Research.
https://www.ncbi.nlm.nih.gov/.../PMC5998003/ - Diakses Juni 2019.
42. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al.
2011. Non-alcoholic fatty liver disease and mortality among US adults:
prospective cohort study. BMJ, 343: d6891.
43. Chiang J. 2014. Liver Physiology:Metabolism and Detoxification. Northeast
Ohi (USA): Elsevier.
44. Tangvarasittichais. 2015. Oxidative stress, insulin resistance dyslipidemia
andtype 2 diabetes mellitus. World Jurnal of Diabetes, 6(3): 456-80.
45. Johansen JS, Harris AK, Rychly DJ, Ergul A. 2005. Oxidative stress and the
use of antioxidants in diabetes: Linking basic science to clinical practice.
Cardiovascular Diabetology, 4(5): 1-11.
46. Winarsi H. 2007. Antioksidan alami dan radikal bebas, potensi dan
aplikasinya dalam kesehatan. Yogyakarta: Kanisius.
47. Towaha J, Balitteri. 2013. Kandungan senyawa kimia pada daun teh
(Camellia sinensis). Warta Penelitian Dan Pengembangan Tanaman Industri.
19(3): 12 – 6.

Fakultas Kedokteran Universitas Andalas 50

48. Bachtiar, A. 1991. Manfaat Gambir. Makalah ada Penataran Petani dan
Pedagang Pengumpul Gambir di Pangkalan. FMIPA Unand. Padang.
49. Rakyat Merdeka On Line (2014). Muba jadikan gambir pengawet makanan.
RMOL SUMSEL Republik Indonesia. http://www.rmolsumsel.com/read/
2014/.../Muba-Jadikan-Gambir-Pengawet-Makanan - Diakses Juni 2019.
50. Isnawati A, Raini M, Sampurno OD, Mutiatikum D, Widowati L, Gitawati R.
2012. Karakteristik tiga jenis ekstrak gambir (Uncaria gambir Roxb) dari
Sumatera Barat. Bul Penelit Kesehat, 40(4): 201-8.
51. Astutiningsih, C., Setyani, W., Hindratna, H. (2014). Uji Daya Antibakteri
Dan Identifikasi. Isolat Senyawa Katekin Dari Daun Teh (Camellia Sinensisl.
Var Assamica). Jurnal Farmasi Sains dan Komunitas, 11(2): 50–57.
52. Murakami C, Hirakawa C, Inui H, Nakano Y dan Yoshida H (2014). Effect of
tea catechin on cellular lipid peroxidation and cytotoxicity in hepG2 cells.
Bioscience, Biotechnology, and Biochemistry, 66(7): 1559 – 62.
53. A’raaf M, Andry SP, Rizkia AW, Ansori FA, Nadiaskara SN. 2016. Uji
Manfaat K-Dgamb: Kawa Daun Gambir (Uncaria gambir) sebagai
Antidiabetes yang prospektif, suatu analisis in-vivo terhadap mencit (Mus
muculus) diinduksi aloksan [PKM] Padang: Fakultas Kedokteran Universitas
Andalas.
54. Fahrudin F, Solihin Duryadi D, Kusumorini N, Ningsih S. 2015. Efektifitas
Ekstrak Gambir (Uncaria gambir (Hunter) Roxb.) sebagai Hepatoprotektor
pada Tikus (Rattus novergicus L.) yang Diinduksi CCl4. J Ilmu Kefarmasian
Indonesia, 13(2): 115 – 22.
55. Nanang Y, Berna E, Laurentia K. 2015. Potensi fraksi etil asetat ekstrak daun
gambir (Uncaria gambir Roxb) sebagai antihiperlipidemia. Jurnal
Kefarmasian Indonesia, 5(1): 1-10.
56. Ostrowska J. Luczac W, Kasacka I, Rozanski A dan Skrzydlewska E (2004).
Green tea protects against ethanol-induced lipid peroxidation in rat organs.
Alcohol, 32: 25 – 32.
57. World Health Organization. 2000. General Guidelines for methodologies on
research and evaluation of traditional medicine. Geneva: WHO.

Fakultas Kedokteran Universitas Andalas 51

58. Charan J, Kantharia ND. 2013. How to calculate sample size in animal
studies. J Pharmacol Pharmacother, 4(4): 303-6.
59. Zainuri, M., dan S. I. Wanandi. 2012. Aktivitas spesifik manganese
superoxide dismutase (MnSOD) dan katalase pada hati tikus yang diinduksi
hipoksia sistemik: hubungannya dengan kerusakan oksidatif. Media Litbang
Kesehatan, 22(2): 87-92
60. Asdaq SMB, Inamdar MN (2010). Potential of Crocus sativus (saffron) and
its constituent, crocin, as hypolipidemic and antioxidant in rats. Applied
biochemistry and biotechnology, 162(2): 358-72.
61. Luka CD, Mohammed A (2013). Effect of Fish Oil on High Lipid Fed Albino
Rats. Journal of Medical and Applied Biosciences, 5(1).
62. Salomo H, Busman.H, Apriliana E. 2018. Pengaruh pemberian metformin
dan ekstrak daun teh hijau pada penurunan berat badan tikus putih (Rattus
novergicus) galur sprague dawley dengan diet tinggi lemak. Jurnal Majority,
7(2); 65-79.
63. Kusumawati D. 2004. Bersahabat dengan hewan coba. Yogyakarta: Gadjah
Mada University Press. hlm 38 – 45.
64. Saklar S, Ertas E, Ozdemir IS. 2015. Effect of different brewing conditions on
catechin content and sensory acceptance in Turkish green tea infusions.
Jfood Sci Technol, 52(10): 6639-46.
65. Hardiningsih R, Nurhidayati N. 2006. Pengaruh pemberian pakan
hiperkolesterolemia terhadap bobot badan tikus putih wistar yang diberi
bakteri asam laktat. Biodiversitas, 7(2): 127-30.
66. Milagro FI, Campion J, Martinez JA. 2006. Weight gain induced by high fat
diet feeding involve increased liver oxidative stress. Obesity (Silver Spring),
14(7): 1118-23.
67. Nagao T, Hase T, Tokimitsu I. 2007. A green tea extract high in catechins
reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring,
MD), 15(6): 1473-83.
68. Park HR, Park M, Choi J, Park KY, Chung HY, Lee J. 2010. A high fat diet
impairs neurogenesis : Involvement of lipid peroxidation and brain-derived
neurotrophicfaction. Neuroscience Letters, 482(3); 235-9.

Fakultas Kedokteran Universitas Andalas 52

69. Samarghandian S, Azimi-Nezhad M, Farkhondeh T. 2017. Catechin
treatment ameliorates diabetes and its complications in streptozotocin-
induced diabetic rats. Dose-Response, 15(1): 1-7.
70. Katzung BG, editor. 2003. Farmakologi dasar & klinik. Edisi 10. Jakarta:
Buku Kedokteran EGC. hlm 10-3.

Fakultas Kedokteran Universitas Andalas 53